Found 11 results

Name Type of Offering Accepted Date
HEMAQUEST PHARMACEUTICALS, INC.
D 2012-03-16
Amount To Be Raised $16,000,000
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-12-000004
Exclusions or Exemptions N/A
Accepted Date 2012-03-16
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D 2018-07-02 14:32:59
Amount To Be Raised $8,500,000
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-07-02 14:32:59
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Debt
Viracta Therapeutics, INC.
D 2017-04-05 14:18:15
Amount To Be Raised $26,875,622
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-17-000004
Exclusions or Exemptions 506b
Accepted Date 2017-04-05 14:18:15
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D 2019-11-05 15:34:03
Amount To Be Raised $24,999,999
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001657369-19-000002
Exclusions or Exemptions 506b
Accepted Date 2019-11-05 15:34:03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D 2020-12-10 16:27:53
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-12-10 16:27:53
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Subsidiary, Inc.
D 2021-03-10 16:39:55
Amount To Be Raised $64,999,994
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001715954-21-000002
Exclusions or Exemptions 506b
Accepted Date 2021-03-10 16:39:55
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
HEMAQUEST PHARMACEUTICALS
D 2010-01-29
Amount To Be Raised $12,651,233
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-10-000004
Exclusions or Exemptions N/A
Accepted Date 2010-01-29
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D 2019-02-12 16:31:52
Amount To Be Raised $5,714,363
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-19-000003
Exclusions or Exemptions 506b
Accepted Date 2019-02-12 16:31:52
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
HEMAQUEST PHARMACEUTICALS
D/A 2010-07-30
Amount To Be Raised $16,124,045
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-10-000005
Exclusions or Exemptions N/A
Accepted Date 2010-07-30
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business WASHINGTON
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D/A 2019-02-12 16:14:33
Amount To Be Raised $10,695,495
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001416377-19-000002
Exclusions or Exemptions 506b
Accepted Date 2019-02-12 16:14:33
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
Viracta Therapeutics, INC.
D 2018-12-13 17:10:22
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001416377
Filed Document 0001607677-18-000004
Exclusions or Exemptions 506b
Accepted Date 2018-12-13 17:10:22
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity